Adar Poonawalla to announce SII coronavirus vaccines by 2021 end, launch Oxford AstraZeneca Covishield by 2020 end

Image Source : FILE PHOTO Serum Institute of India (SII) CEO Adar Poonawalla says they plan to launch their own coronavirus vaccine Adar Poonawalla, the CEO of Serum Institute of India (SII) which is manufacturing 20 crore — 200 million — doses of Oxford-AstraZeneca coronavirus vaccine and seeking phase 3 human trial approval from…

Read More Adar Poonawalla to announce SII coronavirus vaccines by 2021 end, launch Oxford AstraZeneca Covishield by 2020 end

Serum Institute asked to revise protocol to conduct Oxford’s coronavirus vaccine Phase 2, 3 human trials

Image Source : AP Serum Institute of India has been asked by DCGI to revise its protocol to conduct Oxford’s coronavirus vaccine Phase 2, 3 human trials in India. Serum Institute of India (SII), who earlier sought permission to conduct Phase-2 and 3 trials of Oxford University’s coronavirus vaccine in…

Read More Serum Institute asked to revise protocol to conduct Oxford’s coronavirus vaccine Phase 2, 3 human trials